Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism

X. Hu (Wenzhu, China), H. Zhang (Wenzhu, China), S. Meng (Wenzhu, China), F. Lv (Wenzhu, China), L. Lin (Wenzhu, China)

Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Session: Paediatric respiratory infections: mechanistic insights and clinical outcomes
Session type: Thematic Poster
Number: 4636
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
X. Hu (Wenzhu, China), H. Zhang (Wenzhu, China), S. Meng (Wenzhu, China), F. Lv (Wenzhu, China), L. Lin (Wenzhu, China). Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism. 4636

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of sildenafil on mucus hypersecretion of rat airway
Source: Eur Respir J 2007; 30: Suppl. 51, 523s
Year: 2007

Beneficial effects of HDAC6 inhibition on airway epithelial barrier function
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


TLR4 mediates LPS-induced mucus hypersecretion in rat airway
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


A potentiating effect of endogenous nitric oxide in the physiologic secretion from airway submucosal glands
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Source: ERJ Open Res, 7 (1) 00394-2020; 10.1183/23120541.00394-2020
Year: 2021



Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012

Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


The effect of nicotine on COX-dependent airway relaxation and inflammatory mediator expression
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Gastro-oesophageal reflux (GER) and airway responsiveness to methacholine, physical exercise and capsaicin in bronchial asthma: effect of gastric acid secretion inhibition
Source: Eur Respir J 2002; 20: Suppl. 38, 50s
Year: 2002

Mechanisms leading to the bronchoprotective effects of N-Acetylcysteine in human bronchi stimulated by lipopolysaccharide
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018




Effect of 1,25(OH)2D3 on the airway inflammation in asthmatic rat model
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005

Pathogenic mechanisms of melatonin effect on the hyperreactivity and inflammation of the respiratory ways in experiment
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

Club cell 10-kDa protein attenuates airway mucus hypersecretion and inflammation
Source: Eur Respir J 2014; 44: 1002-1010
Year: 2014



Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion
Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018
Year: 2018



Presence of airway SCFAs in asthma and response of airway epithelium to SCFAs
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011


Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Effects of leukotriene receptor antagonists on airway mucus secretion
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001